Drug importers warn government about “secret prices”

Photo: Tablets (archive), via dts news agency

Berlin (dts) – The Association of Pharmaceutical Importers is sharply criticizing the Federal Government's Medical Research Act and the plan by Federal Health Minister Karl Lauterbach (SPD) to no longer make public the amounts reimbursed by health insurance companies to pharmaceutical companies.

Jörg Geller, President of the Federal Association of Pharmaceutical Importers, told Bild (Thursday edition): "The Chancellery and the Minister of Health are on a crash course against everyone. Health insurance companies, doctors, pharmacists, patient advocates, the Federal Council, even parts of the pharmaceutical industry reject secret prices. How secret price agreements are supposed to lead to lower prices remains the secret of the federal government." Only an open market forces all parties to act economically, said Geller. Transparency is "the principle of our market economy."

Lauterbach, on the other hand, defended his plans. The minister also told Bild: "Germany is the only European country that has always made its drug prices transparent. That is why we have the highest prices." The French pay 37 percent less. Germany can no longer be "the paymaster for everyone else," said the minister.